ankylosing spondylitis |
001 |
antioxidant capacity |
001 |
dietary phytochemical index |
001 |
oxidant capacity. |
001 |
adult-onset still’s disease |
011 |
anakinra |
011 |
tocilizumab |
011 |
treatment. |
011 |
carpal tunnel syndrome |
019 |
diagnostic ultrasonography |
019 |
electrophysiology |
019 |
low-level laser therapy. |
019 |
antiphospholipid antibodies |
031 |
antiphospholipid syndrome |
031 |
pakistan |
031 |
pregnancy outcome. |
031 |
atherosclerosis |
040 |
cardiovascular disease |
040 |
carotid intima-media thickness |
040 |
lipoprotein associated phospholipase a2 |
040 |
primary sjögren syndrome. |
040 |
histopathology |
049 |
minor salivary gland |
049 |
sjögren’s syndrome. |
049 |
adverse pregnancy outcomes |
059 |
preeclampsia |
059 |
systemic lupus erythematosus. |
059 |
fibromyalgia syndrome |
067 |
hemodialysis |
067 |
peritoneal dialysis |
067 |
renal transplantation. |
067 |
disease activity score |
077 |
rheumatoid arthritis |
077, 085, 094 |
shoulder joint |
077 |
ultrasound. |
077 |
diagnosis delay |
085 |
disease management |
085 |
therapeutics. |
085 |
dental follicle mesenchymal stem cells |
094 |
synovial fluid. |
094 |
acute phase reactants |
110 |
axial spondyloarthropathy |
110 |
disease activity |
110 |
progranulin. |
110 |
hip |
119 |
knee |
119 |
mini-osteoarthritis knee and hip quality of life |
119 |
osteoarthritis |
119 |
reliability |
119 |
turkish |
119 |
validity. |
119 |
anti-neutrophil cytoplasmic antibody-associated vasculitis |
129 |
cardiovascular risk |
129 |
speckle-tracking echocardiography |
129 |
strain. |
129 |